Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Becker (66424 Homburg, Germany), G. Vella (66424 Homburg, Germany), C. Herr (66424 Homburg, Germany), A. Keller (66123 Saarbrücken, Germany), C. Laczny (66123 Saarbrücken, Germany), C. Beisswenger (66424 Homburg, Germany), R. Bals (66424 Homburg, Germany). The pulmonary microbiome in sarcoidosis is similar to other parenchymal lung diseases. 5208

Member's Comments

No comment yet.

Related content which might interest you: The microbiome in interstitial lung disease Source: Lung Science Conference 2015 Year: 2015 Pulmonary hypertension in different interstitial lung diseases Source: Annual Congress 2012 - Diffuse parenchymal lung disease: clinical profiles and collagen vascular disease Year: 2012 Comparison of registries of interstitial lung diseases in three European countries Source: Eur Respir J 2001; 18: 114S-118S Year: 2001 The epidemiology of idiopathic pulmonary fibrosis and interstitial lung diseases at risk of a progressive-fibrosing phenotype Source: Eur Respir Rev, 27 (150) 180077; 10.1183/16000617.0077-2018 Year: 2018 Pulmonary rehabilitation in interstitial lung diseases compared with chronic obstructive pulmonary disease Source: International Congress 2019 – Pulmonary rehabilitation for non-obstructive lung diseases Year: 2019 History of pulmonary tuberculosis was associated with lung microbiome change in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD Year: 2020 Pulmonary hypertension in interstitial lung disease Source: Eur Respir J 2008; 31: 1357-1367 Year: 2008 Pertechnegas lung clearance in different forms of interstitial lung disease Source: Eur Respir J 2002; 19: 31-36 Year: 2002 Are the gains due to pulmonary rehabilitation in idiopathic pulmonary fibrosis and other interstitial lung diseases the same? Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020 Clinical characteristics of postoperative pulmonary infection in lung cancer patients with obstructive pulmonary disease: the trend of microorganisms in bronchial colonization Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology Year: 2006 The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2019; 83: 158-172 Year: 2019 Pulmonary hypertension in interstitial lung diseases Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease Year: 2009 Differences of acute exacerbations in idiopathic pulmonary fibrosis compared to other fibrotic lung diseases Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis Year: 2019 Morphomolecular motifs of pulmonary neoangiogenesis in interstitial lung diseases Source: Eur Respir J, 55 (3) 1900933; 10.1183/13993003.00933-2019 Year: 2020 Diffuse parenchymal lung diseases Source: ERS Skills Course 2016 Year: 2016 Diffuse parenchymal lung diseases Source: ERS Course 2018 - Summer school of adult respiratory medicine Year: 2018 Diffuse parenchymal lung diseases Source: ERS Course 2019 - Summer school of adult respiratory medicine Year: 2019 Beyond idiopathic pulmonary fibrosis: the world of progressive-fibrosing interstitial lung disease Source: Eur Respir Rev, 27 (150) 180110; 10.1183/16000617.0110-2018 Year: 2018 Diffuse parenchymal lung diseases Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine Year: 2017